Walleye Trading
RNAM

Walleye Trading’s Avidity Biosciences RNAM Stock Holding History

Walleye Trading’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-19,500
Closed -$1.41M – 4613
2025
Q4 		$1.41M Buy
+19,500
New +$1.26M ﹤0.01% 2138

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

Walleye Trading's RNAM Position: Q1 2026 in Review

Walleye Trading sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 2,500 shares — an estimated $180K sold.

Walleye Trading first reported a position in RNAM in Q3 2022 and held it in 2 quarters. The position peaked at $379K in Q3 2022. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • Walleye Trading reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • Walleye Trading sold 2,500 Avidity Biosciences shares in Q1 2026, an estimated $180K.
  • Walleye Trading first reported a position in Avidity Biosciences in Q3 2022 and held it in 2 quarters.
  • Walleye Trading's Avidity Biosciences position peaked at $379K in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on Walleye Trading's 13F filing for Q1 2026, filed 11 May 2026.